Seed Co., Ltd. AI Stock Analysis
Want to see JP:7743 full AI Analyst Report?
Seed Co., Ltd. (7743) AI Stock Analysis
Seed Co., Ltd.
(TSE/TYO:7743)
Seed Co., Ltd.'s moderate score is primarily weighed down by significant fundamental risks, notably escalating debt levels and severe cash burn, which overshadow its steady revenue growth. While the long-term technical trend remains favorable, a premium P/E valuation and overbought momentum indicators limit the stock's near-term appeal.
Seed Co., Ltd. (7743) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 23.79B
- Dividend Yield
- 1.91%
- Average Volume (3M)
- 260.45K
- Price to Earnings (P/E)
- 28.6
- Beta (1Y)
- 0.47
- Revenue Growth
- 4.13%
- EPS Growth
- -39.39%
- Country
- Japan
- Employees
- 1,048
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Seed Co., Ltd. Business Overview & Revenue Model
Company Description
SEED Co.,Ltd. is an international manufacturer and supplier specializing in a broad spectrum of ophthalmic products. The company's extensive range includes various contact lenses, lens care solutions, fashionable spectacle frames, and other vision en...
Seed Co., Ltd. Financial Statement Overview
Summary
Financial health is strained by deteriorating profitability and cash flow. Despite consistent revenue growth to 34.9 billion TTM, net margins have compressed to 2.38%. Heavy capital expenditures have driven free cash flow deeply negative to -6.91 billion, forcing a surge in external financing that pushed the debt-to-equity ratio to a concerning 2.05x.
Income Statement
62PositiveBalance Sheet
45NeutralCash Flow
38Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.93B | 33.94B | 33.23B | 32.40B | 30.59B | 28.84B |
| Gross Profit | 16.00B | 15.22B | 14.63B | 14.18B | 11.62B | 12.01B |
| EBITDA | 5.84B | 4.76B | 5.05B | 5.12B | 2.83B | 4.45B |
| Net Income | 833.49M | 1.14B | 1.09B | 1.96B | -316.09M | 1.15B |
Balance Sheet | ||||||
| Total Assets | 66.25B | 62.50B | 51.76B | 49.57B | 40.01B | 41.79B |
| Cash, Cash Equivalents and Short-Term Investments | 5.53B | 4.21B | 7.12B | 9.89B | 4.94B | 3.88B |
| Total Debt | 39.39B | 28.47B | 26.26B | 24.18B | 20.89B | 22.04B |
| Total Liabilities | 47.09B | 42.90B | 33.38B | 31.92B | 27.87B | 29.25B |
| Stockholders Equity | 19.16B | 19.27B | 18.06B | 17.36B | 11.86B | 12.26B |
Cash Flow | ||||||
| Free Cash Flow | -6.92B | -438.07M | -1.70B | 2.19B | 2.79B | 2.15B |
| Operating Cash Flow | 2.96B | 2.69B | 2.98B | 6.02B | 3.35B | 3.27B |
| Investing Cash Flow | -10.63B | -3.84B | -4.57B | -3.76B | -440.73M | -881.61M |
| Financing Cash Flow | 7.27B | -1.91B | -1.13B | 2.64B | -1.82B | -2.42B |
Seed Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7743, the sentiment is Positive. The current price of 786.00 is above the 20-day moving average (MA) of 785.75, below the 50-day MA of 789.24, and above the 200-day MA of 600.90, indicating a neutral trend. The MACD of 4.19 indicates Positive momentum. The RSI at 72.47 is Negative, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7743.
Seed Co., Ltd. Peers Comparison
Overall Rating
JP:773079Outperform
JP:588969Neutral
JP:304666Neutral
JP:336055Neutral
JP:778055Neutral
JP:774353Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | JPY 147.09B | 20.97 | ― | 2.75% | 10.18% | 55.86% | |
| 69Neutral | JPY 53.81B | 12.39 | ― | 3.84% | 15.36% | 5.16% | |
| 66Neutral | JPY 161.75B | 20.84 | 22.48% | 1.50% | 14.41% | -6.42% | |
| 55Neutral | JPY 228.28B | 17.20 | 9.49% | 2.29% | 6.47% | -3.79% | |
| 55Neutral | JPY 146.24B | 22.94 | 6.65% | 1.46% | 5.60% | 25.38% | |
| 53Neutral | JPY 23.79B | 28.61 | ― | 1.91% | 4.13% | -39.39% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7743 | Seed Co., Ltd. | 786.00 | 231.63 | 41.78% | |
| JP:3046 | JINS HOLDINGS | 6930.00 | 833.61 | 13.67% | |
| JP:7780 | Menicon Co | 1922.00 | 573.53 | 42.53% | |
| JP:3360 | Ship Healthcare Holdings | 2623.00 | 75.26 | 2.95% | |
| JP:5889 | Japan Eyewear Holdings Co.,Ltd. | 2212.00 | 405.55 | 22.45% | |
| JP:7730 | Mani, Inc. | 1493.00 | 86.98 | 6.19% |
Seed Co., Ltd. Corporate Events
Seed Reports Higher Sales and Operating Profit but Lower Net Income
Seed Co., Ltd. is a Tokyo Stock Exchange Standard Market-listed company; the release provides no description of its industry, primary products or market focus.For the six months ended September 30, 2026, consolidated sales rose 5.8% year on year to ¥...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 16, 2026
